Antibiotic resistance in clinical isolates of Pseudomonas aeruginosa in Jamaica

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 16, Issue 2, 2004, Pages 125-130

  Brown, Paul D ^a   Izundu, Anicetus ^b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b Northern Caribbean University   (Jamaica)

Author keywords

Antibiotic resistance; Clinical isolates; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFACLOR; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FOLIC ACID ANTAGONIST; GENTAMICIN; IMIPENEM; KANAMYCIN; MEROPENEM; NALIDIXIC ACID; NORFLOXACIN; PIPERACILLIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTICS;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONFERENCE PAPER; DIFFUSION; DISK DIFFUSION METHOD; DRUG CHOICE; DRUG EFFICACY; EAR; GRAM NEGATIVE INFECTION; HOSPITAL; JAMAICA; MULTIDRUG RESISTANCE; NONHUMAN; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; VAGINA SMEAR; WOUND;

EID: 4544252592     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892004000800008     Document Type: Conference Paper

References (24)

1. Trafny EA. Susceptibility of adherent organisms from Pseudomonas aeruginosa and Staphylococcus aureus strains isolated from burn wounds to antimicrobial agents. Int J Antimicrob Agents. 1998(3);10:223-8.
2. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control. 1999;26: 520-3.
3. Akpaka PE, Sue-Ho, Bodonaik NC. Frequency of occurrence and antibiotic resistance in bacteria isolated from patients in the Intensive Care Unit. West Indian Med J. 2002;51 (Suppl 4):17.
4. Ciofu O, Giwercman B, Pedersen SS, Hoiby N. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF center. APMIS. 1994;102(9):674-80.
5. Dostal RE, Seale JP, Yan BJ. Resistance to ciprofloxacin of respiratory pathogens in patients with cystic fibrosis. Med J Aust. 1992; 156(1):20-4.
6. Mouton JW, den Hollander JG, Horrevorts AM. Emergence of antibiotic resistance among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Antimicrob Chemother. 1993;31(6):919-26.
7. Toscano MA, Minneci M, Salmeri M, Nicoletti G. New epidemiological data on resistance to netilmicin and other aminoglycosides. J Chemother. 1991;3(6):352-6.
8. Kiska DL, Gilligan PH. Pseudomonas. In: Murray PR, Barton EJ, Pfaller MA, Tenover FC, Yolken RH, ed. Manual of clinical microbiology, 7th ed. Washington, D.C.: ASM Press; 1999. Pp. 517-25.
9. Cheesbrough M. Medical laboratory manual for tropical countries. Volume II. Doddington, UK: Tropical Health Technology; 1984.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing. Document M100-S9. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
11. Farrar WE. Antibiotic resistance in developing countries. J Inf Dis. 1985;152(6):1103-6.
12. Ako-Nai AK, Lamikanra AB, Onipede AO. Incidence of pathogenic microorganisms in clinical specimens from hospital in South-Western Nigeria. East Afr Med J. 1995;72(7):436-41.
13. O'Brien TF. Resistance to antibiotics at medical centers in different parts of the world. J Antimicrob Chemother. 1986;18 (Suppl C): 919-26.
14. Li XZ, Livermore DM, Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother. 1994;38(8):1732-41.
15. rd ed. Hyde Park, VT: Antimicrobial Therapy Inc; 2003.
16. Jonas RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest. 2001;119:397s-404s.
17. Bouza E, Garcia-Gorrote F, Cercenado E, Marin M, Diaz MS. Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa study group. Antimicrob Agents Chemother. 1999; 43(4);981-2.
18. Bonfiglio G, Carciotto V, Russo G, Stefani S, Schito GC, Debbia E, et al. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey. J Antimicrob Chemother. 1998;41(2): 307-10.
19. Spencer RC. An 8-year microbe base survey of the epidemiology, frequency and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom. J Antimicrob Chemother. 1996;37(2):295-301.
20. Muller-Premru M, Gubina M. Serotype, antimicrobial susceptibility and clone distribution of Pseudomonas aeruginosa in a university hospital. Zentralbl Bakteriol. 2000;289(8):857-67.
21. Cailleaux V, Mulin B, Capellier G, Julliot MC, Thouverez M, Talon D. Epidemiological study of variations in β-lactam antibiotic susceptibility of Pseudomonas aeruginosa in two intensive care units. J Hosp Infect. 1997;37(3): 217-24.
22. Gencer S, Ak O, Benzonana N, Bat rel A, Ozer S. Susceptibility patterns and cross resistance of antibiotics against Pseudomonas aeruginosa in a teaching hospital of Turkey. Annals Clin Microbiol Antimicrob. 2002;1:2.
23. Naaber P, Koljalg S, Maimets M. Antibiotic usage and resistance-trends in Estonian university hospitals. Int J Antimicrob Agents. 2000;16(3):309-15.
24. Sorberg M, Farra A, Ransjo U, Gardlund B, Rylander M, Settergren B, et al. Different trends in antibiotic resistance rates at a university teaching hospital. Clin Microbiol Infect. 2003;9(3):388-96.